Philip Mazzara Sells 6,801 Shares of Astera Labs (NASDAQ:ALAB) Stock

Posted by Brian Himes on Aug 19th, 2026

Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) General Counsel Philip Mazzara sold 6,801 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the sale, the general counsel owned 96,542 shares in the company, valued at $32,872,551. The trade was a 6.58% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Philip Mazzara also recently made the following trade(s):

On Thursday, May 21st, Philip Mazzara sold 796 shares of Astera Labs stock. The stock was sold at an average price of $291.03, for a total value of $231,659.88.

Astera Labs Stock Down 4.8%

Shares of NASDAQ ALAB traded down $14.42 during trading on Wednesday, reaching $289.02. The company had a trading volume of 4,217,656 shares, compared to its average volume of 5,487,682. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The business’s 50-day moving average is $356.72 and its 200 day moving average is $242.75. The stock has a market cap of $50.14 billion, a PE ratio of 143.08 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the previous year, the firm earned $0.44 EPS. Astera Labs’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Rothschild & Co Redburn initiated coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. Morgan Stanley boosted their price target on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. JPMorgan Chase & Co. upped their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Finally, Evercore reaffirmed an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $333.00.

View Our Latest Report on Astera Labs

Institutional Investors Weigh In On Astera Labs

Large investors have recently added to or reduced their stakes in the stock. Reflection Asset Management purchased a new stake in Astera Labs during the 4th quarter valued at $25,000. Keating Financial Advisory Services Inc. bought a new position in Astera Labs in the second quarter valued at about $25,000. Archer Investment Corp purchased a new position in Astera Labs in the second quarter worth about $30,000. Smartleaf Asset Management LLC boosted its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the last quarter. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in shares of Astera Labs during the 4th quarter valued at about $33,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.